Impact of tumor size on patient survival after radical nephrectomy for pathological T3a renal cell carcinoma

Japanese Journal of Clinical Oncology
Yutaka SugiyamaTomomi Kamba

Abstract

We recently reported the results from a multi-institutional retrospective outcome study involving 814 patients with renal cell carcinomas (RCCs) who had undergone radical surgery and whose diagnoses were confirmed via a central pathological review. This study aimed to clarify the impact of tumor size on survival outcomes in patients with pT3aN0M0 RCC after radical nephrectomy using this cohort. Using the Kaplan-Meier method, overall survival (OS), cancer-specific survival (CSS) and relapse-free survival (RFS) were estimated for 103 pT3aN0M0 patients. The differences in the OS, CSS and RFS according to tumor size were evaluated using the log-rank test. To identify independent prognostic factors that affected each survival outcome, clinicopathological factors were examined using univariate and multivariate analyses, and the Cox proportional hazards model. The OS, CSS and RFS rates for 26 patients with pT3a RCCs ≤4 cm were significantly better than those for 77 patients with pT3a RCCs that were 4-7 cm or >7 cm (P = 0.0064, 0.0169 and 0.0001, respectively). Tumor size and venous invasion were independent prognosticators for OS, CSS and RFS. The OS and CSS for patients with pT3a tumors ≤4 cm were comparable with those for patients w...Continue Reading

References

Feb 24, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G PizzocaroE Marubini
Mar 29, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Edward M MessingUNKNOWN Eastern Cooperative Oncology Group/Intergroup trial
Jun 18, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Joseph I ClarkKim A Margolin
Dec 14, 2004·The Journal of Urology·S SiemerM Stöckle
Apr 18, 2007·The Journal of Urology·Ofer N GofritDov Pode
Oct 29, 2010·European Urology·Juan I Martínez-SalamancaUNKNOWN International Renal Cell Carcinoma-Venous Thrombus Consortium
Oct 11, 2016·The New England Journal of Medicine·Alain RavaudUNKNOWN S-TRAC Investigators
Sep 14, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Robert J MotzerUNKNOWN PROTECT investigators

❮ Previous
Next ❯

Citations

Jun 28, 2021·Revista española de patología : publicación oficial de la Sociedad Española de Anatomía Patológica y de la Sociedad Española de Citología·Ferran Algaba
Oct 2, 2021·Technology in Cancer Research & Treatment·Fangzheng ZhaoNienie Qi
Dec 12, 2021·Genome Biology and Evolution·Antonia Chroni, Sudhir Kumar

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Incidence & Mortality

Cancer has emerged as a global concern due to its increase in incidence and mortality. Efforts are underway to evaluate and develop action plans to reduce the global burden of cancer. Currently, lung cancer, breast cancer and prostate cancer are the leading causes of cancer mortality. Here is the latest research on cancer incidence and mortality.